Ara
Toplam kayıt 8, listelenen: 1-8
Current Practice In Identifying And Treating Cardiovascular Risk, With A Focus On Residual Risk Associated With Atherogenic Dyslipidaemia
(Oxford Univ Press, 2016)
A panel of European experts on lipids and cardiovascular disease discussed clinical approaches to managing cardiovascular risk in clinical practice, including residual cardiovascular risk associated with lipid abnormalities, ...
Prevalence of Potential Familial Hypercholesteremia (Fh) in 54,811 Statin-Treated Patients in Clinical Practice
(Elsevier Ireland Ltd, 2016)
Background and aims: Familial hypercholesterolemia (FH) is a life-threatening disease, characterized by elevated LDL-C levels and a premature, increased risk of coronary heart disease (CHD) that is globally underdiagnosed. ...
Statin-Associated Muscle Symptoms: Impact On Statin Therapy-European Atherosclerosis Society Consensus Panel Statement On Assessment, Aetiology And Management
(Oxford Univ Press, 2015)
Statin-associated muscle symptoms (SAMS) are one of the principal reasons for statin non-adherence and/or discontinuation, contributing to adverse cardiovascular outcomes. This European Atherosclerosis Society (EAS) Consensus ...
Impact Of Lipids On Cardiovascular Health Jacc Health Promotion Series
(Elsevier Science Inc, 2018)
People who maintain ideal cardiovascular heath have a low lifetime risk of cardiovascular disease. Therefore, encouraging people to achieve ideal cardiovascular health represents an important opportunity to improve the ...
Plant Sterols and Plant Stanols in The Management of Dyslipidaemia and Prevention of Cardiovascular Disease
(Elsevier Ireland Ltd, 2014)
Objective: This EAS Consensus Panel critically appraised evidence relevant to the benefit to risk relationship of functional foods with added plant sterols and/or plant stanols, as components of a healthy lifestyle, to ...
Overview Of The Current Status Of Familial Hypercholesterolaemia Care In Over 60 Countries - The Eas Familial Hypercholesterolaemia Studies Collaboration (Fhsc)
(Elsevier Ireland Ltd, 2018)
Background and aims: Management of familial hypercholesterolaemia (FH) may vary across different settings due to factors related to population characteristics, practice, resources and/or policies. We conducted a survey ...
Triglyceride-Rich Lipoproteins And High-Density Lipoprotein Cholesterol In Patients At High Risk Of Cardiovascular Disease: Evidence And Guidance For Management
(Oxford Univ Press, 2011)
Even at low-density lipoprotein cholesterol (LDL-C) goal, patients with cardiometabolic abnormalities remain at high risk of cardiovascular events. This paper aims (i) to critically appraise evidence for elevated levels ...